Literature DB >> 22578371

Reversal of drug-induced anticoagulation: old solutions and new problems.

Walter Sunny Dzik1.   

Abstract

Anticoagulant drugs are taken by millions of patients throughout the world. Warfarin has been the most widely prescribed anticoagulant for decades. In recent years, new oral anticoagulants have been approved for use, are being positioned as alternatives to warfarin, and represent an enormous market opportunity for pharmaceutical companies. Requests for urgent reversal of anticoagulants are not uncommon especially in the setting of critical bleeding. This review summarizes information on reversal of warfarin by vitamin K, plasma, prothrombin complex concentrates, and recombinant VIIa. In addition, we emphasize the lack of current evidence supporting reversibility of the new oral direct thrombin inhibitors and Factor Xa inhibitors. This review is presented to assist transfusion medicine specialists, hematologists, and other clinicians who prescribe blood components for reversal of drug-induced anticoagulation.
© 2012 American Association of Blood Banks.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22578371     DOI: 10.1111/j.1537-2995.2012.03690.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

Review 1.  How we treat bleeding associated with direct oral anticoagulants.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giancarlo M Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2016-01-19       Impact factor: 3.443

Review 2.  Management of oral antiplatelet agents and anticoagulation therapy before bronchoscopy.

Authors:  Houssein A Youness; Jean Keddissi; Ilya Berim; Ahmed Awab
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

Review 3.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

Review 4.  Antiplatelets, anticoagulants, and colonoscopic polypectomy.

Authors:  Neena S Abraham
Journal:  Gastrointest Endosc       Date:  2019-10-01       Impact factor: 9.427

Review 5.  Application of fresh frozen plasma transfusion in the management of excessive warfarin-associated anticoagulation.

Authors:  Yuanyuan Luo; Chunya Ma; Yang Yu
Journal:  Blood Sci       Date:  2022-05-17

6.  Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood.

Authors:  Gines Escolar; Victor Fernandez-Gallego; Eduardo Arellano-Rodrigo; Jaume Roquer; Joan Carles Reverter; Victoria Veronica Sanz; Patricia Molina; Irene Lopez-Vilchez; Maribel Diaz-Ricart; Ana Maria Galan
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

7.  Cutting delays in reversing anticoagulation after intracerebral haemorrhage: three key changes at a UK comprehensive stroke centre.

Authors:  Adrian Parry-Jones
Journal:  BMJ Qual Improv Rep       Date:  2015-06-08

Review 8.  Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines.

Authors:  Francis K L Chan; Khean-Lee Goh; Nageshwar Reddy; Kazuma Fujimoto; Khek Yu Ho; Seiji Hokimoto; Young-Hoon Jeong; Takanari Kitazono; Hong Sik Lee; Varocha Mahachai; Kelvin K F Tsoi; Ming-Shiang Wu; Bryan P Yan; Kentaro Sugano
Journal:  Gut       Date:  2018-01-13       Impact factor: 23.059

Review 9.  Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review.

Authors:  Carlos Galhardo; Luiz Henrique Ide Yamauchi; Hugo Dantas; João Carlos de Campos Guerra
Journal:  Braz J Anesthesiol       Date:  2021-04-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.